Cite
Hepatotoxicity from anabolic androgenic steroids marketed as dietary supplements: contribution from ATP8B1/ABCB11 mutations?
MLA
Stuart Cairns, et al. “Hepatotoxicity from Anabolic Androgenic Steroids Marketed as Dietary Supplements: Contribution from ATP8B1/ABCB11 Mutations?” Liver International, vol. 33, June 2013, pp. 1266–70. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....bd8cba495e609ed718e0c93189030f76&authtype=sso&custid=ns315887.
APA
Stuart Cairns, Sumita Verma, Jonathan R Potts, Adrian Barnardo, A. S. Knisely, Mark R. Howard, & Yasser El Sherrif. (2013). Hepatotoxicity from anabolic androgenic steroids marketed as dietary supplements: contribution from ATP8B1/ABCB11 mutations? Liver International, 33, 1266–1270.
Chicago
Stuart Cairns, Sumita Verma, Jonathan R Potts, Adrian Barnardo, A. S. Knisely, Mark R. Howard, and Yasser El Sherrif. 2013. “Hepatotoxicity from Anabolic Androgenic Steroids Marketed as Dietary Supplements: Contribution from ATP8B1/ABCB11 Mutations?” Liver International 33 (June): 1266–70. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....bd8cba495e609ed718e0c93189030f76&authtype=sso&custid=ns315887.